An underground market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to contact these accounts privately for source information, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where communities with numerous of members share comparison photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Worries
However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering products of unknown origin.
Several experts said the demand for retatrutide could be connected to the increasing price of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, risking fines, legal action or prison.
Platform Reaction and Material Elimination
Based on TikTok, the service has removed problematic material and banned related keywords and query recommendations. The company stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also found groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of slimming results, positive testimonials and detailed instructions for preparing or injecting at home.
Within moments of entering one community, a seller posted contact information, where most transactions occur. The vendor provided an guidebook and guaranteed delivery within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, health issues or past usage.
Item Details and Pricing
Within these communities, messages display dark colored parcels with Royal Mail stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service stated it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they cannot confirm. Even if the science behind this drug is valid, these digital products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she explained.
Her team has already seen individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to potentially serious health risks”.
